Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 2/20 | 0.53 |
| ▸ | AXL | P30530 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | CDK9 | P50750 | 1/20 | 0.40 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.39 |
| ▸ | BACE1 | P56817 | 2/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30343676 | 1.00 | TNF (0.53) | TNFAXLKDM4ELMNACYP1A2 | |
| SCHEMBL28013422 | 0.98 | TNF (0.52) | TNFAXLKDM4ELMNACYP1A2 | |
| Ammonia Solution, Strong SCHEMBL28213837 | 0.98 | TNF (0.52) | TNFAXLKDM4ELMNACYP1A2 | |
| Ammonia Solution, Strong SCHEMBL28213840 | 0.96 | TNF (0.50) | TNFAXLKDM4ELMNACYP1A2 | |
| SCHEMBL30368877 | 0.83 | KDM4E (0.59) | TNFAXLKDM4ELMNACYP1A2 | |
| SCHEMBL196671 | 0.83 | KDM4E (0.59) | TNFAXLKDM4ELMNACYP1A2 | |
| SCHEMBL28109084 | 0.81 | KDM4E (0.57) | TNFAXLKDM4ELMNACYP1A2 | |
| SCHEMBL30477305 | 0.76 | TNF (0.55) | TNFKDM4ELMNACYP1A2CYP3A4 | |
| SCHEMBL29862478 | 0.76 | IMPDH2 (0.47) | TNFAXLKDM4ELMNACYP1A2 | |
| SCHEMBL19656321 | 0.76 | IMPDH2 (0.47) | TNFAXLKDM4ELMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108003100-A | A kind of synthetic method of the nitrogenous heterocyclic aminated compounds of pharmaceutical intermediate | 北京六合宁远科技有限公司 | 2018-05-08 | — | — | CN | claimed |
| CN-104447547-B | Synthesis method of 4-aminoisoquinoline-8-methyl formate | 苏州康润医药有限公司 | 2017-04-19 | — | — | CN | claimed |
| CN-105669547-A | Preparation method of 8-nitro-1,2,3,4-tetrahydroisoquinoline | 苏州大学 | 2016-06-15 | — | — | CN | claimed |
| CN-104447547-A | Synthesis method of 4-aminoisoquinoline-8-methyl formate | SUZHOU KANGRUN PHARMACEUTICALS INC | 2015-03-25 | — | — | CN | claimed |
| CN-103772278-A | Important tetrahydroisoquinoline derivative midbody and synthesis method thereof | Hunan huateng pharmaceutical co ltd | 2014-05-07 | — | — | CN | claimed |
| US-6500954-B1 | ONE POT PROCESS OF BROMINATION AND NITRATION OF ISOQUINOLINE TO PRODUCE SUCH AS 5-BROMO-8-NITROISOQUINOLINE | NEUROSEARCH A/S (DK) | 2002-12-31 | — | — | US | claimed |
| EP-1089976-A1 | METHOD OF PREPARING 5- OR 8-BROMOISOQUINOLINE DERIVATIVES | NEUROSEARCH A/S (DK) | 2001-04-11 | — | — | EP | claimed |
| WO-1999067218-A2 | METHOD OF PREPARING 5- OR 8-BROMOISOQUINOLINE DERIVATIVES | NEUROSEARCH A/S (DK) | 1999-12-29 | — | — | WO | claimed |
| EP-4743457-A1 | INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR THERAPEUTIC USE | 4M THERAPEUTICS INC. (US) | 2026-05-20 | — | — | EP | disclosed |
| CN-121930170-A | Pharmaceutical intermediate with isoquinoline ring and synthesis method thereof | 南通大学 | 2026-04-28 | — | — | CN | disclosed |
| US-20260070945-A1 | MACROCYCLIC IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2026-03-12 | — | — | US | disclosed |
| US-20260022142-A1 | MACROCYCLIC IMMUNOMODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2026-01-22 | — | — | US | disclosed |
| EP-4387963-B1 | PHENYL- AND PYRIDOPYRAZOLE DERIVATIVES AS INHIBITORS OF DDR1 | REDX PHARMA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250367193-A1 | BIFUNCTIONAL COMPOUNDS CONTAINING SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY | NIKANG THERAPEUTICS INC (DE) | 2025-12-04 | — | — | US | disclosed |
| US-4927826-A | Cycloproylpropenamides useful as platelet activing factor (PAF) antagonists | HOFFMAN-LA ROCHE INC. (US) | 1990-05-22 | — | — | US | disclosed |
| US-4927838-A | CARDIOVASCULAR DISORDERS | HOFFMAN-LA ROCHE INC. (US) | 1990-05-22 | — | — | US | disclosed |
| US-4916145-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | HOFFMANN-LA ROCHE INC. (US) | 1990-04-10 | — | — | US | disclosed |
| EP-0299379-A1 | Pentadienamide PAF-antagonists | F. HOFFMANN-LA ROCHE AG (CH) | 1989-01-18 | — | — | EP | disclosed |
| US-4788206-A | CARDIOVASCULAR DISORDERS, PLATELETS | HOFFMANN-LA ROCHE INC. (US) | 1988-11-29 | — | — | US | disclosed |
| US-4786646-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | HOFFMANN-LA ROCHE INC. (US) | 1988-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022142-A1 | MACROCYCLIC IMMUNOMODULATORS | CD274, PDCD1LG2, PDCD1 | TNF 1139/4885AXL 2254/4885KDM4E 522/4885 |
| US-20260070945-A1 | MACROCYCLIC IMMUNOMODULATORS | CD274, PDCD1, PDCD1LG2 | TNF 1275/4885AXL 2165/4885KDM4E 587/4885 |
| US-20250367193-A1 | BIFUNCTIONAL COMPOUNDS CONTAINING SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY | CDK2, SKP2, CCNK | TNF 3795/4885AXL 2017/4885KDM4E 1800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.